Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...

of an Epstein-Barr virus (EBV) vaccine candidate yesterday. The EBV vaccine is being developed in collaboration with Merck, which is known as MSD outside the United States and Canada. Per ...

Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

A researcher at the University of California, San Francisco was honored Saturday for transforming the understanding and treatment of multiple sclerosis, the university said. Dr.

A little over two weeks ago, Akiko Iwasaki and colleagues published “Immunological and Antigenic Signatures Associated with Chronic Illnesses after Covid-19 Vaccination” on medRxiv. You […] ...

Multiple sclerosis is a long-term disease that damages the brain and spinal cord. It happens when the immune system attacks ...

According to studies approximately 15% of cancers are caused by viruses. Read more to know about the viruses that cause cancer.

Trinity researcher’s findings highlight potential causal link between MS and Epstein Barr virus, opening up the possibility ...